Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety evaluation of Fufang Congrong Yizhi Capsule in vascular dementia
ChiCTR2000041358Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fufang congrong yizhi in vascular dementia, sponsored by Xiyuan Hospital. Primary endpoints: Routine blood test, Routine urine test and 3 more. Started Jan 2021; status: recruiting.
02
Drugs
fufang congrong yizhi
03
Conditions
vascular dementia
Beyond the preview
Go deeper on ChiCTR2000041358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041358.